BridgeMD
New treatment option for Keratoconus
Official title Risk Factors and Progression of Keratoconus
ClinicalTrials.gov ID: NCT05676580
What this study is testing
- What it's testing
- Primary objective : Description of keratoconus at baseline and during progression in 200 participants followed by the ophthalmology departments of CHU Montpellier, CHU Bordeaux and CHU Toulouse during a 2-year period. Clinical outcome, histology of the cornea and tears proteomics will be assessed in 4 groups at different points in time: At 6 months in participants with no intervention (risk reduction instructions: not to rub their eyes) At 6 months in participants with no intervention that didn't comply with the risk reduction instructions At 1 month in participants assigned to cross-linking surgery At 1 month in participants assigned to intra corneal ring surgery If both eyes are affected, both will be evaluated with their own visit agenda.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 40
You may be able to join if
- Participants with clinical keratoconus (Rabinowitz criteria with topographic slit lamp abnormalities and visual impairment), preclinical or crude...
- Followed by the ophthalmology services of the CHU Montpellier, CHU Bordeaux or CHU Toulouse
- For adult Participants: collection of written informed consent, after a period of reflection period
- For minors: informed consent signed by at least one of the 2 parents or legal representatives legal representatives, and assent of the child after a...
- Affiliation to the French social security system or beneficiary of such a system
You likely can't join if
- Person under legal supervision, guardianship or curator
- History of corneal implant on both eyes
- Planned relocation before the end of the first stage of treatment (abstention, cross-linking, intra-corneal ring depending on the participant)
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, Occitanie, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, Occitanie, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.